NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results

NAMS Stock   19.85  0.95  4.57%   
Slightly above 60% of NewAmsterdam Pharma's investor base is looking to short. The analysis of the overall investor sentiment regarding NewAmsterdam Pharma suggests that many traders are alarmed. NewAmsterdam Pharma's investing sentiment can be driven by a variety of factors including economic data, NewAmsterdam Pharma's earnings reports, geopolitical events, and overall market trends.
  
Topline data from pivotal Phase 3 TANDEM trial now expected in 4Q 2024 due to faster than expected enrollment On-track to report topline data from pivotal Phase 3 BROADWAY trial in 4Q 2024 Strong balance sheet with 422.7 million in cash as of September 30, 2024 NAARDEN, The Netherlands and MIAMI, Nov. 06, 2024 -- NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-s

Read at finance.yahoo.com
Yahoo News
  

NewAmsterdam Pharma Current Investor Sentiment

Panic Vs Confidence

40

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use NewAmsterdam Pharma's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward NewAmsterdam Pharma.

NewAmsterdam Pharma Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards NewAmsterdam Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

NewAmsterdam Pharma Fundamental Analysis

We analyze NewAmsterdam Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NewAmsterdam Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NewAmsterdam Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

NewAmsterdam Pharma is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

NewAmsterdam Pharma Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NewAmsterdam Pharma stock to make a market-neutral strategy. Peer analysis of NewAmsterdam Pharma could also be used in its relative valuation, which is a method of valuing NewAmsterdam Pharma by comparing valuation metrics with similar companies.

Peers

NewAmsterdam Pharma Related Equities

GLUEMonte Rosa   13.72   
0%
100.0%
CMPXCompass Therapeutics   4.49   
0%
32.0%
CGEMCullinan Oncology   2.75   
0%
20.0%
RZLTRezolute   1.00   
0%
7.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
5.0%
REPLReplimune   0.21   
0%
1.0%
MOLNMolecular Partners   0.17   
1.0%
0%
MRUSMerus BV   0.29   
2.0%
0%
CRNXCrinetics Pharmaceuticals   0.81   
5.0%
0%
PEPGPepGen   0.98   
7.0%
0%
IVAInventiva   1.12   
8.0%
0%
JANXJanux Therapeutics   2.54   
18.0%
0%
MLYSMineralys Therapeutics,   2.59   
18.0%
0%
PRTCPureTech Health   5.04   
36.0%
0%
ELYMEliem Therapeutics   5.88   
42.0%
0%

Additional Tools for NewAmsterdam Stock Analysis

When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.